# Argus Moves Abbott to Hold After 2026 Sales Outlook Cut By John Kim Canonical URL: https://www.tokenpost.com/news/business/42195 Published: 2026-10-28T01:13:22.000Z Updated: 2026-10-28T01:13:22.000Z Section: Business > Abbott’s revised full-year sales target followed 7% comparable-sales growth in the third quarter, while its adjusted earnings midpoint stayed unchanged. Argus Research moved Abbott to Hold Tuesday, Oct. 27, six days after the health care company cut its 2026 comparable-sales growth outlook to about 6% from a 6.5% to 7.5% range. The revised forecast followed 7% comparable-sales growth in the third quarter. Abbott’s comparable-sales measure excludes foreign-exchange effects and certain revenue tied to a multiyear agreement. TokenPost previously covered [Abbott’s sales outlook reduction](). Abbott narrowed its full-year adjusted diluted earnings-per-share range to $5.50 to $5.55 from $5.45 to $5.60, keeping the midpoint unchanged. It projected fourth-quarter adjusted diluted earnings per share of $1.62 to $1.67. ## Links in this article - [Abbott’s sales outlook reduction](https://www.tokenpost.com/news/business/37199)